During the past decade, Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 13 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk" #1 collaborator was "Galapagos NV" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk" are "Arthritis, Rheumatoid" (4 trials), "Psoriatic Arthritis" (3 trials), "Rheumatoid Arthritis" (3 trials), "Systemic Lupus Erythematosus" (2 trials) and "Active Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk" in a lesser frequency.

Most popular intervention types in "Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk" are "Drug" (15 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Filgotinib" (3 trials), "Placebo to match filgotinib" (3 trials), "Adalimumab" (2 trials) and "BI 695501" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".